Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients

Abstract Objectives To address whether the use of methotrexate (MTX) and biological disease-modifying anti-rheumatic drugs (bDMARDs) impacts bone structure and biomechanical properties in patients with psoriatic arthritis (PsA). Methods This is a cross-sectional study in PsA patients receiving no DM...

ver descrição completa

Detalhes bibliográficos

Principais autores:	David Simon, Arnd Kleyer, Sara Bayat, Koray Tascilar, Eleni Kampylafka, Timo Meinderink, Louis Schuster, Ramona Petrov, Anna-Maria Liphardt, Juergen Rech, Georg Schett, Axel J. Hueber
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2019-07-01
coleção:	Arthritis Research & Therapy
Assuntos:	Psoriatic arthritis Bone Disease-modifying anti-rheumatic drugs Biological agents Methotrexate Computed tomography
Acesso em linha:	http://link.springer.com/article/10.1186/s13075-019-1938-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!